Startseite Rituximab therapy in ROHHAD(NET) syndrome
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Rituximab therapy in ROHHAD(NET) syndrome

  • Katherine A.C. Hawton ORCID logo , Rainer Doffinger , Athimalaipet V. Ramanan , Simon C. Langton Hewer , Hazel J. Evans , Dinesh Giri EMAIL logo und Julian P. Hamilton Shield
Veröffentlicht/Copyright: 26. April 2022

Abstract

Objectives

Rapid-onset obesity with hypoventilation, hypothalamic dysfunction, autonomic dysregulation, and neural-crest tumour (ROHHAD(NET)) is a rare syndrome presenting in early childhood associated with high morbidity and mortality. There is no specific diagnostic biomarker and diagnosis is based on clinical features. An autoimmune origin has been postulated.

Case presentation

Management is largely supportive. We report a case of a five-year old female who presented in respiratory arrest after 6-months of rapid weight gain. She had central hypoventilation, central diabetes insipidus, growth hormone deficiency and hyperprolactinaemia. She displayed elevated interleukin-6 levels on cytokine serology which normalised after rituximab treatment. After rituximab treatment, her weight reduced significantly from greatly above the 99.6th to the 50th centile in 12 months.

Conclusions

This response possibly reflects an underlying, immune-inflammatory pathology driving excess adiposity in this condition. Potentially, other aspects of ROHHAD(NET) may be mediated through autoimmune dysregulation in which case rituximab may provide benefits for prognosis and survival.


Corresponding author: Dinesh Giri, MBBS, FRCPCH, MD, MSc, Consultant Paediatric Endocrinology, Bristol Royal Hospital for Children, BS28BJ, Bristol, UK, Phone: 01173429336, E-mail:

Acknowledgments

Research undertaken by JHS is supported by the NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol. The views expressed by those authors and not necessarily those of the NIHR or the Department of Health and Social Care.

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. Reppucci, D, Hamilton, J, Yeh, E, Katz, S, Al-Saleh, S, Narang, I. ROHHAD syndrome and evolution of sleep disordered breathing. Orphanet J Dare Dis 2016;11:106. https://doi.org/10.1186/s13023-016-0484-1.Suche in Google Scholar PubMed PubMed Central

2. Harvengt, J, Gernay, C, Mastouri, M, Farhat, N, Lebrethon, M, Seghaye, M, et al.. ROHHAD(NET) syndrome: systematic review of the clinical timeline and recommendations for diagnosis and prognosis. J Clin Endocr Metab 2020;105:2119. https://doi.org/10.1210/clinem/dgaa247.Suche in Google Scholar PubMed

3. Bougnères, P, Pantalone, L, Linglart, A, Rothenbühler, A, Le Stunff, C. Endocrine manifestations of the rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, and neural tumor syndrome in childhood. J Clin Endocr Metab 2008;93:3971–80. https://doi.org/10.1210/jc.2008-0238.Suche in Google Scholar PubMed

4. Giacomozzi, C, Guaraldi, F, Cambiaso, P, Niceta, M, Verrillo, E, Tartaglia, M, et al.. Anti-hypothalamus and anti-pituitary auto-antibodies in ROHHAD syndrome: additional evidence supporting an autoimmune etiopathogenesis. Horm Res Paediat 2019;92:124–32. https://doi.org/10.1159/000499163.Suche in Google Scholar PubMed

5. Ibáñez-Micó, S, Marcos Oltra, A, de Murcia Lemauviel, S, Ruiz Pruneda, R, Martínez Ferrández, C, Domingo Jiménez, R. Rapid-onset obesity with hypothalamic dysregulation, hypoventilation, and autonomic dysregulation (ROHHAD syndrome): a case report and literature review. Neurologia 2017;32:616–22. https://doi.org/10.1016/j.nrl.2016.04.008.Suche in Google Scholar PubMed

6. Lee, JM, Shin, J, Kim, S, Gee, HY, Lee, JS, Cha, DH, et al.. Rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, and neuroendocrine tumors (ROHHADNET) syndrome: a systematic review. BioMed Res Int 2018;2018:1250721. https://doi.org/10.1155/2018/1250721.Suche in Google Scholar PubMed PubMed Central

7. Filippidou, M, Petropoulou, T, Botsa, E, Vasilakis, I, Smyrnaki, P, Orfanou, I, et al.. ROHHAD syndrome - a still unrecognized cause of childhood obesity: report of three cases. J Pediatr Endocrinol Metabol 2020;33:1341–48. https://doi.org/10.1515/jpem-2020-0111.Suche in Google Scholar PubMed

8. Ido Paz-Priel, M, David, W, Cooke, MD, Chen, AR. Cyclophosphamide for rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome. J Pediatr 2010;158:337–9. https://doi.org/10.1016/j.jpeds.2010.07.006.Suche in Google Scholar PubMed PubMed Central

9. Smith, M. Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance. Oncogene 2003;22:7359–68. https://doi.org/10.1038/sj.onc.1206939.Suche in Google Scholar PubMed

Received: 2022-02-16
Accepted: 2022-03-17
Published Online: 2022-04-26
Published in Print: 2022-08-26

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review Article
  3. Effects of vitamin D supplementation on glycemic control of children and adolescents with type 1 diabetes mellitus: a systematic review
  4. Original Articles
  5. A preliminary study on the relationship between environmental endocrine disruptors and precocious puberty in girls
  6. Tissue concentration of aldosterone in fetal adrenals of intrauterine death cases
  7. Complications of orthopedic treatment in patients diagnosed with X-linked hypophosphatemic rickets
  8. Comparison of insulin sensitivity indices for detection of double diabetes in Indian adolescents with type 1 diabetes
  9. Evaluation of the growth and nutritional status of preschool children: a pilot study in the cold area of China
  10. Arterial hypertension is associated with an increased risk of metabolic complications in pediatric patient with obesity
  11. From pregnancy to breastfeeding: adequate maternal body mass index is essential to prevent a high body mass index in your children
  12. Screening of non-syndromic early-onset child and adolescent obese patients in terms of LEP, LEPR, MC4R and POMC gene variants by next-generation sequencing
  13. The association between vitamin B12, folate, homocysteine levels, and carotid intima-media thickness in children with obesity: a cross-sectional study
  14. Comprehensive assessment of cardiovascular disease risk in children with short stature due to isolated growth hormone deficiency: a case-control study
  15. Visceral adiposity is related to insulin sensitivity and inflammation in adolescents with obesity and mild sleep disordered breathing
  16. Recurrent hypoglycemic seizure as a presenting symptom of post-TBI hypopituitarism in children: a case report, review and proposed protocol
  17. Evaluation of the etiological and clinical characteristics of pediatric central diabetes insipidus
  18. Case Reports
  19. Clinical and radiologic evaluation of a Turkish family with hypochondroplasia and a rare FGFR3 variant
  20. Rituximab therapy in ROHHAD(NET) syndrome
  21. Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: a new treatment strategy with zoledronic acid and Denosumab
  22. A 2-bp deletion mutation in SMPD1 gene leading to lysosomal acid sphingomyelinase deficiency in a Chinese consanguineous pedigree
Heruntergeladen am 1.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2022-0085/html
Button zum nach oben scrollen